FCGR3A and non-small cell lung carcinoma: An additional investigation involving an NSCLC cell line indicates that both NK cells and NK‐92 (an NK‐92 cell line transduced with CD16) can elicit an ADCC response when combined with anti‐PD‐L1 monoclonal antibodies.